– Dee Shortridge, Senior Director, JMI Laboratories (USA)
– Rafael Cantón, Head of Clinical Microbiology Department, Hospital Universitario Ramón y Cajal; Associated Profesor, Complutense University Madrid (Spain)
– Christian Giske, Professor/Chief consultant physician, Department of Laboratory Medicine, Karolinska Institutet (Sweden)
Presentation 1: Pre-clinical antimicrobial susceptibility testing: considerations and challenges (Dee Shortridge) – Steps for developing an in vitro susceptibility test for your lead compound – Studies needed to characterize your compound – Points to consider if your compound is not typical.
Presentation 2: Pitfalls and opportunities of susceptibility testing in clinical trials of new antibiotics (Rafael Cantón) – The introduction of new antimicrobials needs antimicrobial susceptibility testing to define their profile and the alignment with regulators. – Susceptibility testing data are also used to define both clinical and PK/PD breakpoints. – Moreover, they can be used to recognize wild type populations and anticipate emergence or resistance.
Audience questions will be answered at the end of the webinar.
Date and time:
Thu, Mar 2, 2023 5:00 PM – 6:30 PM CET
Dedicated registration link here